Human keratinocytes were treated with varying concentrations of arsenite, zinc or both compounds for 24 h. Chromatin preparation and collection protocols were followed as previously described (King et al., 2012 (
link)). Following collection, chromatin suspension was sonicated on ice (90 s) in immunoprecipitation lysis buffer (0.01 M Tris-HCl, pH 8.0, 0.14 M NaCl, 1% Triton X-100, 0.1% deoxycholate, 1% SDS) using a Branson
Sonifer (output, 3; duty, 40%; pulsed). The samples were isolated by centrifugation (13,000 rpm at 4°C for 15 min) with the supernatant containing cross- linked chromatin. A 50 μl aliquot of the supernatant was used to determine DNA concentration using the
DNeasy blood and tissue kit (Qiagen). For each sample, an equal amount of cross- linked chromatin (40–50 μg) was immunoprecipitated with 0.2 μg of specific antibody (XPA or PARP-1) overnight at 4°C. The immunocomplexes were adsorbed onto
protein A Dynabeads (Invitrogen) for 3 h at 4°C. The samples were washed five times in ChIP wash buffer (Santa Cruz), resuspended in loading buffer, and boiled for 10 min at 95 °C before loading onto a 10% polyacrylamide gel followed by western blotting.
Ding X., Zhou X., Cooper K.L., Huestis J., Hudson L.G, & Liu K.J. (2017). Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and applied pharmacology, 331, 108-115.